SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GZMO
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mike head who wrote (124)10/18/1999 8:34:00 PM
From: scaram(o)uche  Read Replies (2) of 438
 
Mike:

Yup, GENZ as much as said so between the lines. Remember that Hoechst took a license to the CEGE gene activation methods for the TKTX projects.

OTOH, TKTX bristles when asked about this, saying that it was "covering of rear end".

CEGE called it a "partnership".

- g -

Hoechst made the ARIA and CEGE moves at about the same time. They've now backed out of ARIA and failed to take a further interest in CEGE (although the epo and "second protein" licenses stand).

Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News